Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 18613746.
- Also identified by DOI 10.1371/journal.pmed.0050150 and PMC identifier 2443187.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Frank Cobelens and colleagues outline key research questions that need to be addressed to maximize the impact of programmatic management of drug-resistant tuberculosis.
Medical subject headings
- Antitubercular Agents
- Tuberculosis, Multidrug-Resistant